NKG2D受体的Rae1和H60连体刺激瘤免疫
A Diefenbach1, E R Jensen, A M Jamieson
1Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley 94720, USA.
将NKG2D配体Rae1beta或H60引入瘤细胞上,会引发自然杀手 (NK) 细胞和CD8+T细胞的强烈排斥. 这一发现表明NKG2D连接体在开发新型瘤疫苗中的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 自然杀手 (NK) 细胞对于抗瘤免疫力至关重要,但它们与瘤细胞的相互作用尚未完全理解.
- 免疫细胞上的NKG2D受体识别了瘤细胞表达的配体,但与瘤排斥缺乏直接联系.
- 几个NKG2D配体与MHC I类分子相关,在瘤细胞上升调节,但它们在排斥中的作用尚不清楚.
研究的目的:
- 为了研究NKG2D连接体在瘤细胞排斥中的作用.
- 确定瘤细胞上表达NKG2D连接体是否可以诱导抗瘤免疫反应.
- 探索NKG2D连接体在癌症疫苗开发中的潜力.
主要方法:
- 在各种瘤细胞系中,对类NKG2D配体 (Rae1beta或H60) 的异位表达.
- 评估同基因小鼠中的瘤细胞排斥.
- 评估免疫反应,包括NK细胞和CD8+T细胞活动.
- 挑战瘤的小鼠在暴露于结合体表达瘤细胞后.
主要成果:
- 雷1β或H60连接体的子宫外表达导致了同基因小鼠中瘤细胞的强烈排斥.
- 瘤排斥是由NK细胞和CD8+T细胞介导的.
- 结合体表达瘤细胞诱导了细胞毒性T细胞的显著原始化和NK细胞的敏感化 in vivo.
- 暴露于结合体表达瘤细胞的小鼠对随后的瘤挑战产生了特定的免疫力.
结论:
- 在瘤细胞上表达NKG2D配体Rae1beta或H60可以引起强大的抗瘤免疫力.
- NKG2D配体在由NK和CD8+T细胞介导的瘤细胞排斥中发挥着关键作用.
- 这些发现支持NKG2D连接体在有效瘤疫苗设计中的潜在应用.
更多相关视频
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
相关概念视频
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle
Receptor Tyrosine Kinases
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
